Back to results
US 2024/0002818 A1Published application
Mammalian mobile element compositions, systems and therapeutic applications
AssigneeSaliogen Therapeutics, Inc.
InventorsJoseph J. HIGGINS, Ray TABIBIAZAR
Life of this patent
Estimating the term…
Abstract
Recombinant mammalian helper enzymes for targeted transposition are described. The mammalian helper enzymes and corresponding donor DNAs can be used, e.g., for gene therapy.
Claims87
A composition comprising:
- (a) a recombinant helper enzyme, or a nucleotide sequence encoding the same, having gene cleavage (Exc) and/or gene integration (Int) activity and at least about 90% identity to the amino acid sequence of SEQ ID NO:
- 2, and/or
- (b) a gene transfer construct comprises a vector comprising a donor DNA comprising left and right end sequences recognized by the recombinant helper enzyme, the left and right end sequences having at least about 90% identity to the nucleotide sequences of SEQ ID NO:
- 11 and SEQ ID NO:
- 16.
2 more elements
The composition of any one of the above claims, wherein the composition comprises a gene transfer construct.
A composition comprising:
- (a) a recombinant helper enzyme, or a nucleotide sequence encoding the same, having gene cleavage (Exc) and/or gene integration (Int) activity and at least about 90% identity to the amino acid sequence of SEQ ID NO:
- 3, SEQ ID NO:
- 4, SEQ ID NO:
- 6, SEQ ID NO:
- 7, SEQ ID NO:
- 8, or SEQ ID NO:
- 9, and
- (b) a gene transfer construct comprises a vector comprising a donor DNA comprising left and right end sequences recognized by the recombinant helper enzyme, the end sequences having at least about 90% identity to the nucleotide sequences of SEQ ID NO:
- 11 and SEQ ID NO:
- 16.
7 more elements
Dependencies are inferred from the claim text.